These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23970998)

  • 21. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
    Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
    BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.
    Matta A; Ralhan R
    Head Neck Oncol; 2009 Mar; 1():6. PubMed ID: 19284526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cats, Cancer and Comparative Oncology.
    Cannon CM
    Vet Sci; 2015 Jun; 2(3):111-126. PubMed ID: 29061935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.
    Glazer CA; Chang SS; Ha PK; Califano JA
    Oral Oncol; 2009; 45(4-5):440-6. PubMed ID: 18674958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
    Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):703-8. PubMed ID: 1825993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment.
    MacEwen EG
    Cancer Metastasis Rev; 1990 Sep; 9(2):125-36. PubMed ID: 2253312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa.
    Renzi A; De Bonis P; Morandi L; Lenzi J; Tinto D; Rigillo A; Bettini G; Bellei E; Sabattini S
    PLoS One; 2019; 14(4):e0215621. PubMed ID: 30998743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.
    Bowles DW; McDermott JD; Jimeno A
    Future Oncol; 2014 May; 10(6):1065-80. PubMed ID: 24941990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
    Devaraja K; Aggarwal S; Verma SS; Gupta SC
    Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-based therapeutics for head and neck squamous cell carcinoma.
    Tassone P; Old M; Teknos TN; Pan Q
    Oral Oncol; 2013 Aug; 49(8):733-7. PubMed ID: 23623836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.
    Harris K; Gelberg HB; Kiupel M; Helfand SC
    Vet Pathol; 2019 Nov; 56(6):826-839. PubMed ID: 31331247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of genetic targets on therapy in head and neck squamous cell carcinoma.
    Chaikhoutdinov I; Goldenberg D
    Adv Exp Med Biol; 2013; 779():165-77. PubMed ID: 23288639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased p16
    Munday JS; He Y; Aberdein D; Klobukowska HJ
    Vet J; 2019 Jun; 248():64-70. PubMed ID: 31113565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.
    Muzaffar J; Bari S; Kirtane K; Chung CH
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).
    Cohen RB
    Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.